user

CD30-positive malignant lymphomas: time for a change of management?

被引：5
|
作者：
Engert, Andreas [1 ,2 ]
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp Cologne, GHSG, Cologne, Germany
来源：
HAEMATOLOGICA | 2013年 / 98卷 / 08期
关键词：
BRENTUXIMAB VEDOTIN SGN-35; STERNBERG-REED CELLS; HODGKINS LYMPHOMA; DISEASE; POTENT;
D O I：
10.3324/haematol.2013.091561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1165 / 1168
页数：5
相关论文
共 50 条
  • [41] Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
    Abdulla, Farah R.
    Zhang, Weiwei
    Wu, Xiwei
    Honda, Kord
    Qin, Hanjun
    Cho, Hyejin
    Querfeld, Christiane
    Zain, Jasmine
    Rosen, Steven T.
    Chan, Wing C.
    Parekh, Vishwas
    Song, Joo Y.
    BLOOD, 2021, 138
  • [42] CD30-POSITIVE, ANAPLASTIC LARGE-CELL LYMPHOMAS THAT EXPRESS CD15 BUT LACK CD45 - A POSSIBLE DIAGNOSTIC PITFALL
    PERKINS, PL
    ROSS, CW
    SCHNITZER, B
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1992, 116 (11) : 1192 - 1196
  • [43] A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
    Kim, Miso
    Lee, Jeong-Ok
    Koh, Jiwon
    Kim, Tae Min
    Lee, Ji Yun
    Jeon, Yoon Kyung
    Keam, Bhumsuk
    Kim, Dong-Wan
    Lee, Jong Seok
    Heo, Dae Seog
    HAEMATOLOGICA, 2021, 106 (08) : 2277 - 2280
  • [44] Th2 cytokine expression is uncommon in CD30-positive and CD30-negative primary cutaneous T-large cell lymphomas (PCTLCL).
    Vermeer, MH
    vanderStoop, P
    Tensen, CP
    vanOostveen, JW
    Lund, M
    Scheper, RJ
    ThestrupPedersen, K
    Willemze, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 319 - 319
  • [45] Genetic Risk Stratification of CD30-Positive Peripheral T-Cell Lymphomas: Results of a Multi-Institutional Study
    Castellar, E. R. Parrilla
    Jaffe, E. S.
    Said, J.
    Swerdlow, S. H.
    Ketterling, R. P.
    Knudson, R. A.
    Sidhu, J. S.
    Hsi, E. D.
    Karikehalli, S.
    Jiang, L.
    Vasmatzis, G.
    Gibson, S. E.
    Ondrejka, S.
    Nicolae, A.
    Grogg, K. L.
    Allmer, C.
    Ristow, K. M.
    Macon, W. R.
    Law, M. E.
    Cerhan, J. R.
    Habermann, T. M.
    Ansell, S. M.
    Dogan, A.
    Maurer, M. J.
    Feldman, A. L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 860 - 860
  • [46] Infection with parapoxvirus induces CD30-positive cutaneous infiltrates in humans
    Rose, C
    Starostik, P
    Bröcker, EB
    JOURNAL OF CUTANEOUS PATHOLOGY, 1999, 26 (10) : 520 - 522
  • [47] Atopic dermatitis with CD30-positive anaplastic large cell lymphoma
    Yumi Yasukochi
    Katsuto Takenaka
    Ayano Yurino
    Yuichi Kurihara
    Sho Miake
    Hiroshi Uchi
    Satoshi Takeuchi
    Futoshi Kohda
    Yoichi Moroi
    Shinji Okano
    Hidetaka Yamamoto
    Masutaka Furue
    European Journal of Dermatology, 2014, 24 : 132 - 133
  • [48] DETECTION OF HTLV-I PROVIRAL SEQUENCES IN CD30-POSITIVE LARGE CELL CUTANEOUS T-CELL LYMPHOMAS
    ANAGNOSTOPOULOS, I
    HUMMEL, M
    KAUDEWITZ, P
    HERBST, H
    BRAUNFALCO, O
    STEIN, H
    AMERICAN JOURNAL OF PATHOLOGY, 1990, 137 (06): : 1317 - 1322
  • [49] Survivin and BCL2 expression in CD30-positive LPDs of the skin compared to systemic anaplastic large cell lymphomas
    Simonetti, O.
    Goteri, G.
    Rupoli, S.
    Fazioli, F.
    Leoni, P.
    Offidani, A. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S50 - S50
  • [50] CD30-POSITIVE LYMPHOMA INVOLVING PRIMARILY THE ADRENAL-GLANDS
    LIANG, R
    LOKE, SL
    ANNALS OF ONCOLOGY, 1991, 2 (01) : 40 - 40
12345